These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


381 related items for PubMed ID: 30745382

  • 1. Bacterial Cytological Profiling as a Tool To Study Mechanisms of Action of Antibiotics That Are Active against Acinetobacter baumannii.
    Htoo HH, Brumage L, Chaikeeratisak V, Tsunemoto H, Sugie J, Tribuddharat C, Pogliano J, Nonejuie P.
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745382
    [Abstract] [Full Text] [Related]

  • 2. Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens.
    Dillon N, Holland M, Tsunemoto H, Hancock B, Cornax I, Pogliano J, Sakoulas G, Nizet V.
    EBioMedicine; 2019 Aug; 46():193-201. PubMed ID: 31353294
    [Abstract] [Full Text] [Related]

  • 3. Identification of novel in vitro antibacterial action of cloprostenol and evaluation of other non-antibiotics against multi-drug resistant A. baumannii.
    Shahzad S, Willcox M, Shahzad A.
    J Antibiot (Tokyo); 2020 Jan; 73(1):72-75. PubMed ID: 31586155
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates.
    Luna BL, Garcia JA, Huang M, Ewing PJ, Valentine SC, Chu YM, Ye QZ, Xu HH.
    Int J Antimicrob Agents; 2019 Apr; 53(4):474-482. PubMed ID: 30593847
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
    Kuo HY, Chang KC, Kuo JW, Yueh HW, Liou ML.
    Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.
    Shin B, Park W.
    J Microbiol; 2017 Nov; 55(11):837-849. PubMed ID: 29076065
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergy and mechanism of action of α-mangostin and ceftazidime against ceftazidime-resistant Acinetobacter baumannii.
    Pimchan T, Maensiri D, Eumkeb G.
    Lett Appl Microbiol; 2017 Oct; 65(4):285-291. PubMed ID: 28799218
    [Abstract] [Full Text] [Related]

  • 12. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance.
    Lin MF, Lin YY, Tu CC, Lan CY.
    J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688
    [Abstract] [Full Text] [Related]

  • 13. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
    Zavascki AP, Carvalhaes CG, Picão RC, Gales AC.
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fluorescence-Based Detection of Natural Transformation in Drug-Resistant Acinetobacter baumannii.
    Godeux AS, Lupo A, Haenni M, Guette-Marquet S, Wilharm G, Laaberki MH, Charpentier X.
    J Bacteriol; 2018 Oct 01; 200(19):. PubMed ID: 30012729
    [Abstract] [Full Text] [Related]

  • 16. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S, Douraghi M, Adibhesami H, Zeraati H, Rahbar M, Boroumand MA, Aliramezani A, Ghourchian S, Mohammadzadeh M.
    Lett Appl Microbiol; 2016 Dec 01; 63(6):466-472. PubMed ID: 27626896
    [Abstract] [Full Text] [Related]

  • 17. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
    Wieczorek P, Sacha P, Hauschild T, Zórawski M, Krawczyk M, Tryniszewska E.
    Folia Histochem Cytobiol; 2008 Dec 01; 46(3):257-67. PubMed ID: 19056528
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar 01; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA, Kuang SN, Hernandez R, Chong MC, Ewing PJ, Fleischer J, Meng J, Chu S, Terashita D, English L, Chen W, Xu HH.
    BMC Infect Dis; 2016 May 04; 16():194. PubMed ID: 27146090
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.